Statistics about Health, Pharma & Medtech in United States
Statistics
- Charlie'S Holdings, Inc. revenue 2019-2023
- Celldex Therapeutics revenue 2019-2023
- Charlie'S Holdings, Inc. gross profit 2014-2018
- Charlie'S Holdings, Inc. liabilities 2019-2023
- Celldex Therapeutics liabilities 2019-2023
- Celldex Therapeutics operating profit 2019-2023
- Aytu Bioscience gross profit 2020-2024
- Neutra Corp. revenue 2019-2022
- Neuropathix, Inc. total equity 2017-2021
- Aytu Bioscience net cash 2020-2024
- Cell Source total assets 2019-2023
- Celldex Therapeutics net cash 2019-2023
- Nanoviricides total equity 2020-2024
- Nanomix Corp total equity 2018-2022
- Aytu Bioscience liabilities 2019-2023
- Aytu Bioscience operating profit 2020-2024
- Celldex Therapeutics total equity 2019-2023
- Celldex Therapeutics total assets 2019-2023
- Nektar Therapeutics total equity 2019-2023
- Cerevel Therapeutics Holdings, Inc. total equity 2019-2023
- Cerevel Therapeutics Holdings, Inc. operating profit 2019-2023
- Cerevel Therapeutics Holdings, Inc. total assets 2019-2023
- Cerevel Therapeutics Holdings, Inc. liabilities 2019-2023
- Cerevel Therapeutics Holdings, Inc. net income 2019-2023
- Cerevel Therapeutics Holdings, Inc. net cash 2019-2023
- Charlie'S Holdings, Inc. net income 2014-2019
- Cell Source operating profit 2019-2023
- Tharimmune net cash 2020-2023
- Checkpoint Therapeutics net income 2022-2023
- Checkpoint Therapeutics total assets 2019-2023
- Axim Biotechnologies liabilities 2019-2023
- Cincor Pharma, Inc. total assets 2020-2021
- Axim Biotechnologies net income 2019-2023
- Cincor Pharma, Inc. operating profit 2020-2021
- Cincor Pharma, Inc. net income 2020-2021
- Cincor Pharma, Inc. net cash 2020-2021
- Nexien Biopharma, Inc. operating profit 2020-2021
- Checkpoint Therapeutics operating profit 2019-2023
- Charlie'S Holdings, Inc. total equity 2019-2023
- Neutra Corp. liabilities 2018-2022
- Charlie'S Holdings, Inc. total assets 2019-2023
- Axim Biotechnologies operating profit 2019-2023
- Checkpoint Therapeutics net cash 2019-2023
- Cincor Pharma, Inc. total equity 2019-2021
- Axim Biotechnologies total assets 2019-2023
- Axim Biotechnologies gross profit 2016-2020
- Axim Biotechnologies revenue 2019-2023
- Checkpoint Therapeutics liabilities 2019-2023
- Charlie'S Holdings, Inc. net cash 2019-2023
- Neutra Corp. operating profit 2018-2022
- Checkpoint Therapeutics total equity 2019-2023
- Axim Biotechnologies net cash 2019-2023
- Neutra Corp. gross profit 2019-2022
- Charlie'S Holdings, Inc. operating profit 2019-2023
- Axim Biotechnologies total equity 2019-2023
- Cell Source net income 2018-2021
- Nexien Biopharma, Inc. liabilities 2017-2023
- Cell Source liabilities 2019-2023
- Cell Source net cash 2019-2023
- Aytu Bioscience total equity 2020-2024
- Aytu Bioscience total assets 2020-2024
- Avenue Therapeutics net income 2020-2023
- Chromadex Corp. gross profit 2019-2023
- Cingulate Inc. total assets 2020-2023
- Nexien Biopharma, Inc. total equity 2019-2023
- Chromadex Corp. revenue 2019-2023
- Aceragen operating profit 2018-2022
- Aceragen net income 2018-2022
- Neuropathix, Inc. net cash 2017-2021
- Chromadex Corp. liabilities 2019-2023
- Aceragen revenue 2017-2022
- Aceragen total assets 2018-2022
- Nanomix Corp net cash 2018-2022
- Cidara Therapeutics net cash 2019-2023
- Aceragen net cash 2018-2022
- Aceragen liabilities 2018-2022
- Cidara Therapeutics total assets 2019-2023
- Aceragen total equity 2018-2022
- Neutra Corp. total equity 2018-2022
- Ars Pharmaceuticals revenue 2021-2023
- Cidara Therapeutics total equity 2019-2023
- Nanoviricides net cash 2020-2024
- Chromadex Corp. operating profit 2019-2023
- Cidara Therapeutics liabilities 2019-2023
- Cidara Therapeutics operating profit 2019-2023
- Cidara Therapeutics revenue 2022-2023
- Ars Pharmaceuticals net cash 2020-2023
- Ars Pharmaceuticals operating profit 2020-2023
- Nektar Therapeutics net cash 2019-2023
- Ars Pharmaceuticals liabilities 2020-2023
- Avenue Therapeutics liabilities 2019-2023
- Avenue Therapeutics operating profit 2019-2023
- Terns Pharmaceuticals net income 2020-2023
- Cingulate Inc. total equity 2019-2023
- Tevogen Bio Holdings Inc. total equity 2021-2023
- Neuropathix, Inc. total assets 2017-2021
- Celcuity total assets 2019-2023
- Celularity Inc liabilities 2019-2023
- Celularity Inc net cash 2019-2023
- Neutra Corp. total assets 2018-2022